Global Biz News Room

Where Business Goes Global

Home-Business-Medistep Healthcare Limited’s IPO Receives Overwhelming Response , Subscribed 356 Times
Medistep Healthcare Limited’s IPO Receives Overwhelming Response , Subscribed 356 Times

BusinessAdmin8/15/2025

Mumbai, August 15, 2025 – Medistep Healthcare Limited, a fast-growing player in the healthcare and medical device manufacturing sector, has successfully closed its Initial Public Offering (IPO), receiving an overwhelming response from investors across categories. The IPO was subscribed a remarkable 356.25 times, reflecting strong investor confidence in the company’s growth trajectory and future prospects.

The fixed-price issue of 37,44,000 equity shares at â‚ą43 per share, aggregating to a total issue size of â‚ą16.09 crore, witnessed bids for an impressive 1,33,38,15,000 shares.

Category-wise Subscription Details:

  • Qualified Institutional Buyers (QIBs): 2,46,63,000 shares
  • Non-Institutional Investors (NIIs): 48,90,18,000 shares
  • Retail Individual Investors (RIIs): 82,01,34,000 shares

IPO Structure:

  • Retail Investors Quota: Not less than 17,79,000 equity shares
  • Non-Institutional Investors Quota: Not more than 17,76,000 equity shares
  • Market Maker: 1,89,000 equity shares

The issue opened on August 8, 2025, and closed on August 12, 2025. The equity shares are set to be listed on August 18, 2025.

Company Overview & Use of Proceeds

Medistep Healthcare Limited plans to utilize the net proceeds from the IPO towards:

  • Capital expenditure for the purchase of plant and machinery for expansion at its existing manufacturing facility
  • Working capital requirements
  • General corporate purposes

With the successful completion of the IPO, the company’s post-issue equity shares stand at 1,42,09,546, with a post-issue implied market capitalization of ₹61.10 crore.

IPO Details at a Glance:

  • Face Value: â‚ą10 per share
  • Issue Price: â‚ą43 per share
  • Lot Size: 3,000 equity shares
  • Pre-Issue Equity: 1,04,65,546 shares
  • Post-Issue Equity: 1,42,09,546 shares

Issue Intermediaries:

  • Lead Manager: Fast Track Finsec Private Limited
  • Registrar: Cameo Corporate Services Limited

The extraordinary subscription numbers reflect strong market trust in Medistep Healthcare’s vision and execution capabilities. The company is well-positioned to enhance its manufacturing footprint and continue delivering quality healthcare solutions.